Value Creation KEY VALUE DRIVERS CSL’S VALUE CREATION CYCLE CSL’s ultimate goal is to deliver value through fulfilling unmet patient needs and protecting public health. With patients and public health at the core of our focus, we also strive to deliver sustainable financial growth for our shareholders and other stakeholders who rely on our operations for economic and social prosperity. CODE OF RESPONSIBLE BUSINESS PRACTICE SALES, MARKETING, POLICY EARLY STAGE RESEARCH MANUFACTURING PRODUCT DEVELOPMENT & COLLABORATION & DISTRIBUTION & CLINICAL TRIALS POLICY ADVOCACY & PATIENT SUPPORT + READ MORE AT INVESTORS.CSL.COM CSL’s people More than 29,000 people with diverse skills that drive the CSL’s Values and purpose Solutions for unmet needs Opportunities to improve and protect the quality of life of patients and communities in CSL’s therapeutic areas Business partners Accessing and sharing intellectual know-how to develop and innovate CSL products Physical assets Plasma donation centres to collect vital raw material, manufacturing facilities for CSL products, warehouses, research and development facilities and offices for CSL’s people Natural resources Plasma donations for rare and serious diseases; influenza virus strains for vaccine manufacture; iron sources (including synthetic) for iron-based products; and environmental inputs such as water and energy to enable reliable supply of therapies and vaccines to patient communities Financial resources Cash, equity and debt for future growth 14 Performance
RkJQdWJsaXNoZXIy MjE2NDg3